Prescott Deininger PhD

Prescott Deininger PhD

Associate Director, Basic Science, Tulane Cancer Center

   My laboratory studies the way human mobile elements contribute to insertional mutagenesis and recombination in cancer, and the influences of DNA repair deficiencies.

Genetic instability is one of the most critical contributors to cancer.  Human mobile elements have the potential to contribute to genetic instability both because of their capability of insertional mutagenesis as well as their presence as repetitive DNA sequences in the genome that can contribute to mutagenic recombination events.  Both of these processes a greatly stimulated, but to variable extents, in different tumors.  We have studied the epigenetic mechanisms that control the expression of a small number of the 500,000 L1 elements that are active in any given tumor type.  Our data support the likelihood that there are typically only one or two potentially active L1 loci expressed in any given tumor and that the exact loci are different between tumors, as well as polymorphic between individuals.  We are working on a study to determine whether individual loci may serve as ‘risk’ loci for cancer incidence or progression, particularly in prostate cancer.

We have also developed a reporter assay to measure the influence of Alu elements on the recombination process.  We have shown that the relative amount of this recombination, as well as the specific mechanism and products formed, differs between different tumors.  This is largely dependent on the nature of the underlying DNA repair defects in the tumors.  Our studies are beginning to lay the framework for understanding these forms of instability in response to various environmental insults and interns of forming different types of mutagenic footprints.    

ORCID ID: 0000-0002-1067-3028

 

MyNCBI:   https://www.ncbi.nlm.nih.gov/myncbi/prescott.deininger.1/bibliography/public/

 

Key Publications:

  1. Maria E. Morales, Travis B.     White, Vincent A. Streva, Cecily B. DeFreece, Dale J. Hedges and Prescott     L. Deininger (2015)   The contribution of Alu elements to     mutagenic DNA double-strand break repair. PLOS Genetics 11, e1005016     (PMCID PMC4356517)
  2. P Deininger, ME Morales, TB White, M Baddoo, DJ Hedges, G     Servant, S Srivastav, ME Smither, M Concha, DL DeHaro, EK Flemington, VP     Belancio (2016) A     comprehensive approach to expression of L1 loci.      Nucleic Acids Research, doi:     10.1093/nar/gkw1067. PMID: 27899577.
  3. G Servant,     VA Streva, RS Derbes, MI Wijetunge, M Neeland, TB White, VP Belancio, and     AM Roy-Engel and PL Deininger (2017) The Nucleotide Excision     Repair pathway limits L1 retrotransposition. Genetics 205: 139-153.
  4. Morales ME, Kaul T, Walker J, Everett C, White T, Deininger     P. (2021) Altered DNA repair creates novel Alu/Alu     repeat-mediated deletions.

Hum Mutat. 2021 May;42(5):600-613. doi: 10.1002/humu.24193. Epub2021 Mar 19.

  1. Freeman B, White T, Kaul T, Stow EC, Baddoo M,     Ungerleider N, Morales M, Yang H, Deharo D, Deininger P, Belancio     VP (2022) Analysis of epigenetic features characteristic of L1 loci     expressed in human cells. Nucleic Acids Res 50(4):1888-1907. doi:     10.1093/nar/gkac013

 

 

Keywords:      genetic instability; Retroelements; mobile elements; DNA repair; insertional mutagenesis; recombination;

 

https://medicine.tulane.edu/departments/hayward-genetics-center-tulane-center-aging-biochemistry-molecular-biology-adjunct

Publications  

Click Here For PubMed Publications

LCRC Faculty

Sven Davisson CRA
Louisiana Cancer Research Center
Arrigo De Benedetti, PhD
Cancer Biology
LSU Health - New Orleans
Prescott Deininger PhD
Genes X Environment
Tulane University School of Medicine
Luis Del Valle MD
Genes X Environment
LSU Health - New Orleans
Wu-Min Deng PhD
Cancer Biology
Tulane University School of Medicine
Dilip Depan, PhD
Translational Oncology
University of Louisiana Lafayette
Stassi DiMaggio PhD
Translational Oncology
Xavier University
Carroll Diaz, Jr., PhD
Population Sciences
Xavier University
Huangen Ding, PhD
Translational Oncology
Louisiana Tech University